Boston, MA 05/15/2014 (wallstreetpr) – Hologic, Inc. (NASDAQ:HOLX) is a noted name in the medical technology ground, which deals with developing, manufacturing and supplying premium diagnostic and surgical products. The company emphasizes on women healthcare and requirements. On May 15, 2014, it announced to showcase its latest Tomcat instrument on the 114th General Meeting in American Society for Microbiology.
Hologic to exhibit the latest instrument:
A developer and supplier of medical technology said that the company will exhibit the instrument in American Society for Microbiology (ASM2014), which will be held from May 17 -20, 2014 at Boston Convention and Exhibit Centre, in Boston, Massachusetts.
A brief about the Tomcat instrument:
According to Hologic, Inc. (NASDAQ:HOLX), Tomcat tool is completely automated general function platform designed to lessen the strain of pre-analytical samples. It works by abolishing the incompetent and error-prone activities required to manually aliquot samples. However, the professionals of Hologic will start commercializing the unique instrument from June 2014. Rohan Hastie, PhD, Hologic’s Division President, Diagnostics acknowledged that this very instrument lessen the burden of manual sample transfer steps. It in turn will help in accomplishing a high volume of laboratory work and enhance productivity.
Robert W. McMahon to be the new Chief Financial Officer:
The report dated May 13, 2014 from the company’s desk signifies great news for future. Robert W. McMahon has been designated to the Chief Financial Officer of Hologic, Inc. (NASDAQ:HOLX). The role will come to action from May 26, 2014. Needless to say, Robert joined the company after having 20 years of experience in the financial segment. He previously worked at the senior position of Johnson & Johnson. He was also the global Vice President of Finance and Business Development at Ortho Clinical Diagnostics.
Other changes:
Robert will come at the position of Glenn Muir, who will be retiring from Hologic’s Chief Financial Officer Role. However, he will be there in the company for assistance till November 30, 2014. On the flip side, Peter J. Valenti III will join as Hologic, Inc. (NASDAQ:HOLX)’s Division President; breast Health from May 26, 2014. Such designation change will surely help the company to proceed towards a better success!
